The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 144 affiliates in 45 countries and more than 37,000 employees. Since it was founded in 1885, the privately-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
They are a research-driven group of companies dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.Their business consists of Prescription Medicines, Consumer Health Care and Animal Health. Activities grouped under Industrial Customer, include Pharma Chemicals and Biopharmaceuticals.
Boehringer Ingelheim set up its China branch office in March 1994. A year later, Boehringer Ingelheim International Trade (Shanghai) Co., Ltd. was registered. In 1998, Shanghai Boehringer Ingelheim Pharmaceuticals Ltd. was established in Shanghai Zhangjiang High-tech park. The total investment amounts to 29 Mio US$ marking the beginning of the company’s continuous investment to China. The Zhangjiang Plant has introduced state-of-art manufacturing facility with design, equipment, and management standard that are on a par with those in the plants of other countries. The plant production strictly follows the international GMP standard. Currently the company has offices in Shanghai, Beijing, Guangzhou, Chengdu with over 500 employees.
Boehringer Ingelheim’s business in China is organized into three divisions focusing on prescription medicines, consumer healthcare and animal health, covering major markets in the country. The company spares no effort in bringing innovative pharmaceutical products to China market, and as a result, Boehringer Ingelheim has obtained a strong recognition for the excellence of its product pipeline covering therapeutic areas, ranging from respiratory, cardiovascular and central nerve system medicines to anti-AIDS medicines.
Business in China:
Business (es): Human Pharmaceuticals, Animal Health
Number of employees (2006): 578
Net Sales with third parties (2006): 56 million EUR
Best selling Prescription Medicines products (2006):
Mucosolvan® lurenorm® icardis® trovent®Actilyse®
Best selling Consumer Health Care products (2006):Mucosolvan®
Best selling Animal Health products (2006):
Ingelvac®Aujeszky, Ingelvac®PRRS, Ingelvac®M.hyo, Ingelvac®AR4, Ingelvac®H